SLC25A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.485600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.738800E-01
Normal-vs-Stage2
3.917400E-01
Normal-vs-Stage3
6.469000E-01
Normal-vs-Stage4
2.744200E-01
Stage1-vs-Stage2
5.984200E-01
Stage1-vs-Stage3
8.089000E-01
Stage1-vs-Stage4
7.571600E-01
Stage2-vs-Stage3
9.820200E-01
Stage2-vs-Stage4
9.250800E-01
Stage3-vs-Stage4
9.697800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.733400E-01
Normal-vs-AfricanAmerican
5.103800E-01
Normal-vs-Asian
8.159600E-02
Caucasian-vs-AfricanAmerican
9.510800E-01
Caucasian-vs-Asian
1.713400E-01
AfricanAmerican-vs-Asian
4.334600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.072000E-01
Normal-vs-Female
4.232400E-01
Male-vs-Female
5.123000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.599600E-01
Normal-vs-Age(41-60Yrs)
2.763600E-01
Normal-vs-Age(61-80Yrs)
4.010600E-01
Normal-vs-Age(81-100Yrs)
4.049600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.306800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.752800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.544400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.760800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.785200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.842400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.650600E-01
Normal-vs-Daily Drinker
3.248400E-01
Normal-vs-Weekly Drinker
5.724100E-02
Normal-vs-Occasional Drinker
3.339400E-01
Normal-vs-Social Drinker
4.539800E-01
Non Drinker-vs-Daily Drinker
7.829400E-01
Non Drinker-vs-Weekly Drinker
6.621400E-01
Non Drinker-vs-Occasional Drinker
5.171800E-01
Non Drinker-vs-Social Drinker
5.062800E-01
Daily Drinker-vs-Weekly Drinker
4.916200E-01
Daily Drinker-vs-Occasional Drinker
7.202600E-01
Daily Drinker-vs-Social Drinker
6.875000E-01
Weekly Drinker-vs-Occasional Drinker
2.464200E-01
Weekly Drinker-vs-Social Drinker
2.817200E-01
Occasional Drinker-vs-Social Drinker
9.259600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.140800E-01
Normal-vs-Grade 2
2.251000E-01
Normal-vs-Grade 3
7.530800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.295600E-01
Grade 1-vs-Grade 3
4.157000E-01
Grade 1-vs-Grade 4
4.140800E-01
Grade 2-vs-Grade 3
5.890300E-02
Grade 2-vs-Grade 4
2.251000E-01
Grade 3-vs-Grade 4
7.530800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.875600E-01
Normal-vs-NonDiabetic
2.076400E-01
Diabetic-vs-NonDiabetic
6.920200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.037030E-01
Normal-vs-NoPancreatitis
3.330800E-01
Pancreatitis-vs-NoPancreatitis
1.154490E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.419600E-01
Normal-vs-N1
4.002400E-01
N0-vs-N1
3.706800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.270800E-01
Normal-vs-TP53-NonMutant
6.337800E-01
TP53-Mutant-vs-TP53-NonMutant
9.297800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
